Clinical Trial Update: Study of the CycloPen Micro-Interventional System and Long-Term Clinical Outcomes

View source ↗

Summary

Enrollment is ongoing by invitation for the CycloPen Micro-Interventional System in open-angle glaucoma, with long-term clinical outcomes being studied.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• CycloPen Micro-Interventional System

Snippet

Sponsor: Iantrek, Inc. | Conditions: Open Angle Glaucoma | Status: ENROLLING_BY_INVITATION